Tip 2 Diyabette Fizyopatolojik Tedavi Yaklaşımı ve Pioglitazonun Yeri

Tip 2 Diyabette Fizyopatolojik Tedavi Yaklaşımı ve Pioglitazonun Yeri

Modern diyabet tedavi yaklaşımlarına rağmen diyabetik hastaların %50’den fazlasında glisemik kontroller yetersizdir. Glisemik kontrollerinin yeterince gerçekleştirilememesinde hasta, hekim ve sağlık sistemini ilgilendiren faktörler söz konusu olmakla beraber hastalığın progresif bir karakterde olma...

Full description

Bibliographic Details
Main Authors:	Abdulhalim Şenyiğit, Mustafa Kanat
Format:	Article
Language:	English
Published:	Hayat Sağlık ve Sosyal Hizmetler Vakfı (Life Health and Social Services Foundation) 2017-09-01
Series:	Anadolu Kliniği Tıp Bilimleri Dergisi
Subjects:	Diyabet mellitus Pioglitazon İnsülin Direnci Type 2 diabetes (T2DM) pioglitazone
Online Access:	http://dergipark.gov.tr/anadoluklin/issue/31198/284462?publisher=hsv

Similar Items

Tip 2 Diyabette Koroner Arter Hastalığı Varlığı Serebrovasküler Hastalık İçin Bir Risk Faktörü müdür?
by: Abdulhalim Şenyiğit
Published: (2018-09-01)

DİYET VE DİYABET
by: Nebihat Sefil, et al.
Published: (2015-03-01)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
by: Schwartz S
Published: (2010-07-01)

The use of oral thiazoldinediones in correction of hormonal abnormalities among unmarried women with resistant PCO .
by: Wisam Akram, et al.
Published: (2007-01-01)

Effects of Chronic Administration of Pioglitazone on Learning and Memory in Rat Model of Streptozotocin-induced Alzheimer’s Disease
by: Ehsan Aali, et al.
Published: (2020-10-01)

Role of insulin resistance in pathogenesis of diabetes mellitus type 2
by: M I Balabolkin, et al.
Published: (2003-01-01)

Efficacy of Early Combined Therapy with Metformin and Pioglitazone in Patients with Diabetes Mellitus Type 2
by: V.I. Pankiv
Published: (2012-03-01)

Usage of pioglitazone at Medanta, the Medicity
by: Ambrish Mithal, et al.
Published: (2014-01-01)

Effects of Pioglitazone and Irbesartan on Endothelial Dysfunction on Experimentally Streptozotocin-Induced Diabetic Nephropathy in Rats
by: Magdy I. Attallah, et al.
Published: (2018-07-01)

Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
by: K. Kavitha, et al.
Published: (2016-02-01)

Determination of Pioglitazone Hydrochloride in Tablets by High-Performance Liquid Chromatography
by: AMR Lotfy Saber
Published: (2008-12-01)

Pioglitazone: A boon we know less about
by: Dilip Gude
Published: (2013-01-01)

Probiotics ameliorate pioglitazone-associated bone loss in diabetic rats
by: Ahmad Gholami, et al.
Published: (2020-09-01)

Effects of Pioglitazone or Exercise in Older Adults with Mild Cognitive Impairment and Insulin Resistance: A Pilot Study
by: Kerry L. Hildreth, et al.
Published: (2015-02-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Effect of Pioglitazone and Levo-Carnitine on Plasma Glucose, Insulin Resistance and Serum Adiponectin in Type 2 Diabetic Mice
by: Shahida Parveen
Published: (2014-06-01)

Diyabette Leptin Hormonun Olası Etkileri
by: Eylem Taşkın Güven, et al.
Published: (2019-07-01)

Metformin and Pioglitazone Reduce Gene Expression of Inflammatory Factors in Insulin Resistant and Hypertrophied Adipocytes
by: Zahra Malekpour-Dehkordi, et al.
Published: (2020-12-01)

Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study
by: Yi-Chih Hung, et al.
Published: (2020-06-01)

Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of metformin plus sulfonylurea
by: Kirandeep Kaur
Published: (2014-02-01)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
by: V Balaji, et al.
Published: (2014-01-01)

Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01)

A pharmacokinetic and pharmacodynamic study of pioglitazone in a model of induced insulin resistance in normal horses
by: Wearn, Jamie Macquarie
Published: (2014)

The Effect of Aqueous Extract of Quercus Infectoria on Insulin Resistance and Free Fatty Acids in Insulin-Resistant Rats Induced by a High-Fructose Diet
by: Hossein Fallah, et al.
Published: (2021-03-01)

Die insulinsparende Wirkung von Pioglitazon bei dialysepflichtigen Patienten mit Diabetes mellitus Typ II
by: Hauswald, Corinna Katharina
Published: (2014)

Effects of Resveratrol on pharmacokinetics and pharmacodynamics of Pioglitazone in Diabetic rats
by: Raju Devde1 , Narasimha Reddy Y2 , Sravanthi K3 , Abid Ali4 , Imran Khan5
Published: (2017-04-01)

NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation
by: Chiara De Nuccio, et al.
Published: (2020-09-01)

Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients
by: Young Ki Lee, et al.
Published: (2013-12-01)

Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study
by: Vijayam Balaji
Published: (2013-01-01)

Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study
by: Jan Galle, et al.
Published: (2012-05-01)

Pioglitazone Lowers Serum Retinol Binding Protein 4 by Suppressing its Expression in Adipose Tissue of Obese Rats
by: Chaoyu Zhu, et al.
Published: (2015-01-01)

Pioglitazone Attenuates Palmitate-Induced Inflammation and Endoplasmic Reticulum Stress in Pancreatic β-Cells
by: Seok-Woo Hong, et al.
Published: (2018-03-01)

Ellagic acid potentiates insulin sensitising activity of pioglitazone in L6 myotubes
by: Rakesh P. Nankar, et al.
Published: (2015-05-01)

Effekte von Pioglitazon auf das linksventrikuläre Remodeling nach Myokardinfarkt an der Maus
by: Witzel, Catharina-Clara
Published: (2007)

Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
by: Ivan Ramirez-Moral, et al.
Published: (2021-08-01)

Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome
by: Maliheh Amirian, et al.
Published: (2021-08-01)

Comparative Effect of Insulin Sensitizers and Statin on Metabolic Profile and Ultrasonographical Score in Non Alcoholic Fatty Liver Disease
by: Himanshu Rana, et al.
Published: (2016-08-01)

Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
by: Jin-Soo Park, Ph.D, et al.
Published: (2019-04-01)

Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome
by: Ghada Abdel Fattah, et al.
Published: (2014-03-01)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
by: Marit de Jong, et al.
Published: (2017-10-01)